• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
TONG Yuqing,YANG Mengnan,CUI Meirong,YIN Tingjie.Advances in targeting pancreatic cancer-associated fibroblasts[J].Journal Of Pharmaceutical Research,2022,41(12):815-820[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2369times   Download 2607次 QR Code for this article
Scan with your phone!
胰腺癌相关成纤维细胞的靶向调控进展
仝宇晴,杨梦楠,霍美蓉,殷婷婕
Font:Larger+|Default|Smaller-
(中国药科大学药学院药剂系,江苏 南京 211198)
摘要:
胰腺癌相关成纤维细胞(pancreatic cancer-associated fibroblasts, PCAFs)是胰腺癌基质中最主要的细胞成分之一,是胰腺癌纤维结缔组织过度增生的主要贡献者。胰腺癌相关成纤维细胞还能与胰腺癌细胞和免疫细胞发生广泛而多样的串扰,促进胰腺癌的增殖、侵袭和转移,增强胰腺癌对化疗、放疗和免疫治疗的抗性。因此,胰腺癌相关成纤维细胞已成为胰腺癌治疗的一个热门靶标。本文从胰腺癌相关成纤维细胞的来源、特性和生物学作用出发,对近年来用于抑制胰腺癌相关成纤维细胞活性的药物以及可提高胰腺癌相关成纤维细胞药物靶向递送效率的策略进行了综述和分析,以期为进一步提高胰腺癌的治疗效果提供新思路。
关键词:  胰腺癌  胰腺癌相关成纤维细胞  胰腺星状细胞  肿瘤微循环  药物递送
DOI:10.13506/j.cnki.jpr.2022.12.009
基金项目:国家自然科学基金(No.81972835、82003305、81872424)
Publication Date:December 25, 2022
Advances in targeting pancreatic cancer-associated fibroblasts
TONG Yuqing,YANG Mengnan,CUI Meirong,YIN Tingjie
(Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing 211198, China)
Abstract:
Pancreatic cancer-associated fibroblasts (PCAFs), one of the most abundant stroma cell types in pancreatic cancer, are the key inducers of fibrotic and desmoplastic microenvironment. PCAFs also promote tumor proliferation and metastasis by intensive and diverse crosstalk with pancreatic cancer cells as well as immune cells, and play an important role in the resistance against chemo-, radio- and immunotherapies. Therefore, PCAFs has become a popular target in pancreatic cancer treatment. In this review, based on the origin, characteristic and biological function of PCAFs, advances in therapeutic drugs and potential targeted delivery strategies against PCAFs were reviewed and analyzed, in the hope of providing new ideas for further improving the therapeutic outcome against pancreatic cancer.
Key words:  Pancreatic cancer  Pancreatic cancer-associated fibroblasts  Pancreatic stellate cells  Tumor microenvironment  Drug delivery
Today's Visits:485    Total Visits:2383197
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.